Japan has approved the use of the experimental anti-viral drug remdesivir, for the treatment of coronavirus patients with severe symptoms.
The US Food and Drug Administration has authorized remdesivir for emergency use in patients with severe Covid-19.
The Japanese Ministry of Health and Welfare granted special approval of the drug, developed by the US’s Gilead Pharmaceutical, just three days after it applied for approval.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.